US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

243.09

+20.099.01%

Post-market: 242.99-0.1000-0.04%19:48 EDT

Volume:607.41K

Turnover:144.84M

Market Cap:637.99M

PE:- -

High:246.22

Open:223.71

Low:222.45

Close:223.00

52wk High:341.93

52wk Low:102.35

Shares:2.62M

Float Shares:2.62M

Volume Ratio:1.01

T/O Rate:23.14%

Dividend:0.91

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Lupin Wins U.S. FDA Tentative Nod for Novel Apixaban Oral Suspension

Zydus Lifesciences' US Office FDA Inspection Ends With No Observations

MT Newswires Live

EBR Systems Says US FDA Completes Inspection of New California Facility; Shares Up 4%

MT Newswires Live

Wall Street Analysts Are Bullish on Top Healthcare Picks

EBR Systems advances FDA approval process for new WiSE manufacturing site

Analyst Reiterates Buy on Nektar as Legal Overhang Clears, REZPEG Outlook Strengthens and $178 Price Target Remains Unchanged

Analysts Offer Insights on Healthcare Companies: Oncolytics Biotech (ONCY) and Spyre Therapeutics (SYRE)

Supreme Court Clears Independent Forensic Audit of Fortis Healthcare

Analysts Have Conflicting Sentiments on These Healthcare Companies: Roivant Sciences (ROIV) and Johnson & Johnson (JNJ)

Aster DM Quality Care Secures Shareholder Nod on Postal Ballot Resolutions

Aster DM Quality Care Closes Trading Window Ahead of September Quarter Results

LifeSci Capital Remains a Buy on Pyxis Oncology (PYXS)

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Revvity (RVTY)

Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)

Legal Lecture Hall: Qin Tian Explains the Law — "Employing Over-Age Workers Is Not the Same as Employing Them Casually" — A Quick Look at What the New Rules on Protecting the Rights of Over-Age Workers Say

Vital Infrastructure Property Trust Raises $300 Million in Debenture Offering and Calls Series H Notes

Healthcare Triangle Amends Equity Funding Agreement Terms

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/LABU/news?page=21"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":243.09,"timestamp":1791576000000,"preClose":223,"halted":0,"volume":607412,"hourTrading":{"tag":"盘后","latestPrice":242.99,"preClose":243.09,"latestTime":"19:48 EDT","volume":2186,"amount":530052.4267000001,"timestamp":1791589689799,"change":-0.1,"changeRate":-0.000411,"amplitude":0.004484},"delay":0,"changeRate":0.09008968609865473,"floatShares":2624500,"shares":2624500,"eps":0,"marketStatus":"Post-Mkt","change":20.09,"latestTime":"10-09 19:50:23 EDT","open":223.71,"high":246.22,"low":222.45,"amount":144842572.62436,"amplitude":0.106592,"askPrice":247.8,"askSize":200,"bidPrice":242.08,"bidSize":1,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791590400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":223,"sharesOutstanding":3074486,"nav":227.52,"aum":597123938.28,"dividendRate":0.003761,"bidAskSpread":0.003146,"preHourTrading":{"tag":"盘前","latestPrice":223.28,"preClose":223,"latestTime":"09:28 EDT","volume":2212,"amount":498293.87776,"timestamp":1791552512789,"change":0.28,"changeRate":0.001256,"amplitude":0.01487},"postHourTrading":{"tag":"盘后","latestPrice":242.99,"preClose":243.09,"latestTime":"19:48 EDT","volume":2186,"amount":530052.4267000001,"timestamp":1791589689799,"change":-0.1,"changeRate":-0.000411,"amplitude":0.004484},"volumeRatio":1.013214,"impliedVol":0.9666,"impliedVolPercentile":0.7052},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2624500,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.013214,"shares":2624500,"dividePrice":0.9143,"high":246.22,"amplitude":0.106592,"preClose":223,"low":222.45,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":243.09,"committee":-0.99005,"eps":0,"divideRate":0.003761,"volume":607412,"delay":0,"ttmEps":0,"open":223.71,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":248.72,"twentyDayClose":261.3,"sixtyDayClose":254.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:21,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670285199","title":"Lupin Wins U.S. FDA Tentative Nod for Novel Apixaban Oral Suspension","url":"https://stock-news.laohu8.com/highlight/detail?id=2670285199","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670285199?lang=en_us&edition=fundamental","pubTime":"2026-09-28 12:34","pubTimestamp":1790570051,"startTime":"0","endTime":"0","summary":"Lupin Limited ( ($IN:LUPIN) ) has issued an announcement. Lupin Limited has secured tentative approval from the U.S. FDA for its Apixaban Oral Susp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lupin-wins-u-s-fda-tentative-nod-for-novel-apixaban-oral-suspension?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lupin-wins-u-s-fda-tentative-nod-for-novel-apixaban-oral-suspension?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670229288","title":"Zydus Lifesciences' US Office FDA Inspection Ends With No Observations","url":"https://stock-news.laohu8.com/highlight/detail?id=2670229288","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670229288?lang=en_us&edition=fundamental","pubTime":"2026-09-28 11:07","pubTimestamp":1790564876,"startTime":"0","endTime":"0","summary":"Zydus Lifesciences (BOM:532321, NSE:ZYDUSLIFE) said a U.S. Food and Drug Administration inspection of its pharmacovigilance and post-marketing surveillance system at its New Jersey office concluded with no observations, according to a Saturday exchange filing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670055400","title":"EBR Systems Says US FDA Completes Inspection of New California Facility; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670055400","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670055400?lang=en_us&edition=fundamental","pubTime":"2026-09-28 10:22","pubTimestamp":1790562130,"startTime":"0","endTime":"0","summary":"EBR Systems  said the US Food and Drug Administration  has completed its inspection of the company's new California manufacturing facility, according to a Monday filing with the Australian bourse.The inspection was carried out in relation to the company's pre-market approval supplement to add the facility as a manufacturing site for the WiSE System, its lead-less left ventricular endocardial pacing device designed for cardiac resynchronization therapy in heart failure patients, the filing said.The US FDA investigator issued a Form FDA 483 listing two routine observations, which the company has \"promised to correct.\"Facility approval is anticipated by year-end, per the filing.EBR Systems shares rose 4% in morning trade Monday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","EBR.AU","LABU","BK4585","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402934","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402934","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402934?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:10","pubTimestamp":1790554207,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mesoblast Limited (MEOBF) and Cogstate Ltd (COGZF) w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-353?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-353?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0128526141.USD","BK4588","LABU","MEOBF","BK4585","BK4167","COGZF","BK4581","XBI","HCSG","BK4137","LU0029874061.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402990","title":"EBR Systems advances FDA approval process for new WiSE manufacturing site","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402990","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402990?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:08","pubTimestamp":1790554084,"startTime":"0","endTime":"0","summary":"The latest announcement is out from EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:EBR) ). EBR Systems, developer of the WiSE wi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","LABU","FRTY","LFSC","IYH","PSCH","BBP","SYNB","IBB","XLVX","BK4588","TBXU","PINK","MEDI","BK4585","TECB","BMED","NVIB","GNMX","MRNX","RSPH","IEIH","GDOC","EES","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670995404","title":"Analyst Reiterates Buy on Nektar as Legal Overhang Clears, REZPEG Outlook Strengthens and $178 Price Target Remains Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2670995404","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670995404?lang=en_us&edition=fundamental","pubTime":"2026-09-28 06:45","pubTimestamp":1790549119,"startTime":"0","endTime":"0","summary":"Nektar Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst on September 25. Analyst Julian Harrison from BTIG reite...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-nektar-as-legal-overhang-clears-rezpeg-outlook-strengthens-and-178-price-target-remains-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-nektar-as-legal-overhang-clears-rezpeg-outlook-strengthens-and-178-price-target-remains-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","XBI","BK4585","BK4581","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670740486","title":"Analysts Offer Insights on Healthcare Companies: Oncolytics Biotech (ONCY) and Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670740486","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670740486?lang=en_us&edition=fundamental","pubTime":"2026-09-28 05:30","pubTimestamp":1790544629,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Oncolytics Biotech (ONCY) and Spyre Therapeutics (SYRE). Oncolyti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-oncolytics-biotech-oncy-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-oncolytics-biotech-oncy-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","ONCY","LU0029874061.USD","LU0128526141.USD","LFSC","BK4581","BK4139","BK4588","HCSG","LABU","SYRE","XLV","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670240875","title":"Supreme Court Clears Independent Forensic Audit of Fortis Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2670240875","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670240875?lang=en_us&edition=fundamental","pubTime":"2026-09-27 15:42","pubTimestamp":1790494962,"startTime":"0","endTime":"0","summary":"Fortis Healthcare Ltd. ( ($IN:FORTIS) ) has issued an update. Fortis Healthcare Ltd. said the Supreme Court of India has disposed of its Special Le...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/supreme-court-clears-independent-forensic-audit-of-fortis-healthcare?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/supreme-court-clears-independent-forensic-audit-of-fortis-healthcare?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","MNDmain","BK4581","XBI","BK4585","LU0029874061.USD","LU0128526141.USD","BK4588","BK4137","LABU","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670889472","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Roivant Sciences (ROIV) and Johnson & Johnson (JNJ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670889472","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670889472?lang=en_us&edition=fundamental","pubTime":"2026-09-27 01:00","pubTimestamp":1790442018,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roivant Sciences (ROIV) and Johnson & Johnson (JNJ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roivant-sciences-roiv-and-johnson-johnson-jnj-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roivant-sciences-roiv-and-johnson-johnson-jnj-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PJP","JNJ","LU0069063385.USD","LU1629891620.HKD","PTH","LU0912757837.SGD","GDOC","LU1674673428.USD","IYH","BK4532","LU2756315664.SGD","XBI","IHE","FTXH","LU1430594728.SGD","LU0738911758.USD","TRUH","MEDX","LU2750360997.AUD","BK4581","BK4585","LABU","LU0943347566.SGD","IE00BSNM7G36.USD","XLV","LU0234570918.USD","IE00BDGV0183.EUR","FHLC","LU1929549753.HKD","IXJ","VHT","LU0053666078.USD","LU0124676726.USD","LU0426417589.USD","LU2430703095.HKD","LU1280957306.USD","LU0058720904.USD","JDOC","ROIV","BMED","LU0289739343.SGD","LU2403377893.USD","LU1061106388.HKD","BK4588","LU0545562505.USD","HCSG","BK4550","RXL","LU0234572021.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670474927","title":"Aster DM Quality Care Secures Shareholder Nod on Postal Ballot Resolutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2670474927","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670474927?lang=en_us&edition=fundamental","pubTime":"2026-09-26 23:03","pubTimestamp":1790435008,"startTime":"0","endTime":"0","summary":"The latest update is out from Aster DM Healthcare Ltd. ( ($IN:ASTERDM) ). Aster DM Quality Care Limited, formerly Aster DM Healthcare Limited, is a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-secures-shareholder-nod-on-postal-ballot-resolutions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-secures-shareholder-nod-on-postal-ballot-resolutions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4588","XLV","LABU","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670942474","title":"Aster DM Quality Care Closes Trading Window Ahead of September Quarter Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2670942474","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670942474?lang=en_us&edition=fundamental","pubTime":"2026-09-26 23:03","pubTimestamp":1790434991,"startTime":"0","endTime":"0","summary":"Aster DM Healthcare Ltd. ( ($IN:ASTERDM) ) has provided an update. Aster DM Quality Care Limited has announced the closure of its trading window fo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-closes-trading-window-ahead-of-september-quarter-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-closes-trading-window-ahead-of-september-quarter-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LABU","XLV","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670474592","title":"LifeSci Capital Remains a Buy on Pyxis Oncology (PYXS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670474592","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670474592?lang=en_us&edition=fundamental","pubTime":"2026-09-26 22:35","pubTimestamp":1790433318,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Pyxis Oncology today and set a price target of $8.00. Slutsky covers the Healthcare ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-remains-a-buy-on-pyxis-oncology-pyxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-remains-a-buy-on-pyxis-oncology-pyxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XLV","BK4585","XBI","BK4588","BK4139","PYXS","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670471236","title":"Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Revvity (RVTY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670471236","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670471236?lang=en_us&edition=fundamental","pubTime":"2026-09-26 21:00","pubTimestamp":1790427637,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alnylam Pharma (ALNY) and Revvity (RVTY). Alnylam ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alnylam-pharma-alny-and-revvity-rvty-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alnylam-pharma-alny-and-revvity-rvty-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B64QTZ34.USD","LU0889565916.HKD","LU0882574055.USD","LU0320765992.SGD","LU0114720955.EUR","LU0029874061.USD","BK4137","IE00BN0W2V16.EUR","RVTY","XLV","BK4585","IE00BLDYK493.USD","BK4588","BK4581","HCSG","ALNY","XBI","LU0128526141.USD","LU0109394709.USD","BK4139","BK4121","GNMX","IE00BN0W2W23.USD","LABU","BK4548","PBE","LU0054578231.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670471177","title":"Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670471177","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670471177?lang=en_us&edition=fundamental","pubTime":"2026-09-26 20:40","pubTimestamp":1790426416,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Agilent (A) and Regeneron (REGN) with bullish sentim...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-agilent-a-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-agilent-a-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","LU2413666699.HKD","LU2468319806.SGD","LU2041044095.USD","LU2023250504.SGD","LU2092937221.SGD","REGN","LU0053666078.USD","IE00BN0W2T93.GBP","LU0889565916.HKD","LU0114720955.EUR","LU1917777945.USD","LU1974910355.USD","BK4137","LU0029874061.USD","LU0128526141.USD","BK4588","BK4581","LU2362541513.USD","IBBQ","LU2237438978.USD","LU2413666426.HKD","LU0823434583.USD","LU2362540622.SGD","LU0320765992.SGD","LU0058720904.USD","HCSG","A","LU0347712357.USD","XLV","LU1543694498.USD","IE00BN0W2W23.USD","XBI","LU1165135440.EUR","BK4139","LU2362541273.HKD","LU2229751404.USD","LU0109394709.USD","IE00BN0W2V16.EUR","LABU","LU2089279066.USD","BK4121","BBH","LU0823416689.USD","LU0823434740.USD","LU2106854487.HKD","LU0289739699.SGD","BK4585","IBB","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165832259","title":"Legal Lecture Hall: Qin Tian Explains the Law — \"Employing Over-Age Workers Is Not the Same as Employing Them Casually\" — A Quick Look at What the New Rules on Protecting the Rights of Over-Age Workers Say","url":"https://stock-news.laohu8.com/highlight/detail?id=1165832259","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165832259?lang=en_us&edition=fundamental","pubTime":"2026-09-26 14:55","pubTimestamp":1790405741,"startTime":"0","endTime":"0","summary":"Spreading legal knowledge: the relevant law, the Interim Provisions on the Protection of the Basic Rights and Interests of Over-Age Workers.Article 1 These Provisions are formulated in accordance...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LABU","BK4588","XLV","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670427739","title":"Vital Infrastructure Property Trust Raises $300 Million in Debenture Offering and Calls Series H Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2670427739","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670427739?lang=en_us&edition=fundamental","pubTime":"2026-09-26 07:08","pubTimestamp":1790377737,"startTime":"0","endTime":"0","summary":"The latest announcement is out from NorthWest Healthcare Properties REIT ( ($TSE:VITL.UN) ). Vital Infrastructure Property Trust has priced a $300 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vital-infrastructure-property-trust-raises-300-million-in-debenture-offering-and-calls-series-h-notes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vital-infrastructure-property-trust-raises-300-million-in-debenture-offering-and-calls-series-h-notes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IVRA","DFRA","YLDW","BK4581","BPRE","XLV","BK4585","IQRA","REIT","RJMG","XBI","LABU","PSCF","RNTY","MDIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670411427","title":"Healthcare Triangle Amends Equity Funding Agreement Terms","url":"https://stock-news.laohu8.com/highlight/detail?id=2670411427","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670411427?lang=en_us&edition=fundamental","pubTime":"2026-09-26 06:53","pubTimestamp":1790376829,"startTime":"0","endTime":"0","summary":"Healthcare Triangle ( ($HCTI) ) has issued an announcement. On September 22, 2026, Healthcare Triangle amended its June 12, 2026 equity purchase ag...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healthcare-triangle-amends-equity-funding-agreement-terms?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healthcare-triangle-amends-equity-funding-agreement-terms?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4215","EQR","BK4167","REZ","XLV","BK4585","XBI","BK4588","HCTI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":21,"totalSize":417,"code":"91000000","status":"200"}]}}